A spotlight on the interplay between Wnt/β-catenin signaling and circular RNAs in hepatocellular carcinoma progression
- PMID: 37546393
- PMCID: PMC10403753
- DOI: 10.3389/fonc.2023.1224138
A spotlight on the interplay between Wnt/β-catenin signaling and circular RNAs in hepatocellular carcinoma progression
Abstract
Hepatocellular carcinoma (HCC) is one of the deadliest cancers due to multifocal development and distant metastasis resulting from late diagnosis. Consequently, new approaches to HCC diagnosis and treatment are required to reduce mortality rates. A large body of evidence suggests that non-coding RNAs (ncRNAs) are important in cancer initiation and progression. Cancer cells release many of these ncRNAs into the blood or urine, enabling their use as a diagnostic tool. Circular RNAs (CircRNAs) are as a members of the ncRNAs that regulate cancer cell expansion, migration, metastasis, and chemoresistance through different mechanisms such as the Wnt/β-catenin Signaling pathway. The Wnt/β-catenin pathway plays prominent roles in several biological processes including organogenesis, stem cell regeneration, and cell survival. Aberrant signaling of both pathways mentioned above could affect the progression and metastasis of many cancers, including HCC. Based on several studies investigated in the current review, circRNAs have an effect on HCC formation and progression by sponging miRNAs and RNA-binding proteins (RBPs) and regulating the Wnt/β-catenin signaling pathway. Therefore, circRNAs/miRNAs or RBPs/Wnt/β-catenin signaling pathway could be considered promising prognostic and therapeutic targets in HCC.
Keywords: Wnt signaling; circRNA; hepatocellular carcinoma; mechanism; non-coding RNA.
Copyright © 2023 Mafi, Rismanchi, Malek Mohammadi, Hedayati, Ghorbanhosseini, Hosseini, Gholinezhad, Mousavi Dehmordi, Ghezelbash, Zarepour, Taghavi, Asemi, Alimohammadi and Mirzaei.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
The emerging role of non-coding RNAs in the Wnt/β-catenin signaling pathway in Prostate Cancer.Pathol Res Pract. 2024 Feb;254:155134. doi: 10.1016/j.prp.2024.155134. Epub 2024 Jan 14. Pathol Res Pract. 2024. PMID: 38277746 Review.
-
Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways.J Hepatocell Carcinoma. 2021 Nov 25;8:1415-1444. doi: 10.2147/JHC.S336858. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 34858888 Free PMC article. Review.
-
EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.Cancer Biol Ther. 2019;20(7):1007-1016. doi: 10.1080/15384047.2019.1595276. Epub 2019 Mar 31. Cancer Biol Ther. 2019. PMID: 30929558 Free PMC article.
-
Circular RNAs Regulate Cancer Onset and Progression via Wnt/β-Catenin Signaling Pathway.Yonsei Med J. 2019 Dec;60(12):1117-1128. doi: 10.3349/ymj.2019.60.12.1117. Yonsei Med J. 2019. PMID: 31769242 Free PMC article. Review.
-
Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the Wnt signaling pathway.Front Pharmacol. 2023 Sep 27;14:1269233. doi: 10.3389/fphar.2023.1269233. eCollection 2023. Front Pharmacol. 2023. PMID: 37829301 Free PMC article. Review.
Cited by
-
The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways.Noncoding RNA Res. 2024 May 21;9(4):1178-1189. doi: 10.1016/j.ncrna.2024.05.010. eCollection 2024 Dec. Noncoding RNA Res. 2024. PMID: 39022676 Free PMC article. Review.
-
Comprehensive profiling of extrachromosomal circular DNAs in colorectal cancer progression.Sci Rep. 2024 Nov 18;14(1):28519. doi: 10.1038/s41598-024-70455-x. Sci Rep. 2024. PMID: 39557922 Free PMC article.
-
Exosomal PSM-E inhibits macrophage M2 polarization to suppress prostate cancer metastasis through the RACK1 signaling axis.Biomark Res. 2024 Nov 14;12(1):138. doi: 10.1186/s40364-024-00685-8. Biomark Res. 2024. PMID: 39538297 Free PMC article.
-
Deciphering the Enigmatic Influence: Non-Coding RNAs Orchestrating Wnt/β-Catenin Signaling Pathway in Tumor Progression.Int J Mol Sci. 2023 Sep 10;24(18):13909. doi: 10.3390/ijms241813909. Int J Mol Sci. 2023. PMID: 37762212 Free PMC article. Review.
-
The emerging role of circular RNAs in cisplatin resistance in ovarian cancer: From molecular mechanism to future potential.Noncoding RNA Res. 2024 May 20;9(4):1280-1291. doi: 10.1016/j.ncrna.2024.05.005. eCollection 2024 Dec. Noncoding RNA Res. 2024. PMID: 39040815 Free PMC article. Review.
References
-
- Chang W-T, Bow Y-D, Fu P-J, Li C-Y, Wu C-Y, Chang Y-H, et al. . A marine terpenoid, heteronemin, induces both the apoptosis and ferroptosis of hepatocellular carcinoma cells and involves the ROS and MAPK pathways. Oxid Med Cell Longevity (2021) 2021:7689045. doi: 10.1155/2021/7689045 - DOI - PMC - PubMed
-
- Moeinabadi-Bidgoli K, Rezaee M, Rismanchi H, Mohammadi MM, Babajani A. Mesenchymal stem cell-derived antimicrobial peptides as potential anti-neoplastic agents: new insight into anticancer mechanisms of stem cells and exosomes. Front Cell Dev Biol (2022) 10:900418. doi: 10.3389/fcell.2022.900418 - DOI - PMC - PubMed
-
- Wang W, Huang Z, Guo B, Liu S, Xiao W, Liang J. Short- and long-term outcomes of laparoscopic hepatectomy in elderly patients with hepatocellular carcinoma. J BUON (2018) 23(4):971–8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources